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The traditional Tibetan medicine Yukyung
Karne exhibits a potent anti-metastatic
activity by inhibiting the epithelial to
mesenchymal transition and cell migration
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Abstract
Background: In Traditional Tibetan medicine, Yukyung Karne has been used for the treatment of ovarian cancer.
Though Yukyung Karne has been reported to be clinically effective, the molecular mechanism of its anti-metstatic
action remains elusive.
Methods: The cytotoxic property of Yukyung Karne was evaluated by crystal violet staining while its ability to induce
ceramide production was analyzed by sphingomyelinase assay. The anti-metastatic property was investigated using
adhesion, invasion, migration and colony formation assays. The effect of Yukyung Karne on the expression of extracellular
matrix components, and epithelial and mesenchymal markers were evaluated by confocal microscopy and
western blotting.
Results: Yukyung Karne exhibited a strong anti-metastatic property by significantly reducing the invasion,
migration and colony formation ability of ovarian cancer cells. Besides it inhibited the levels of biomarkers
involved in epithelial to mesenchymal transition such as down-regulation of vimentin and N-cadherin and
up-regulation of epithelial E-cadherin. Yukyung Karne also induced the neutral sphingomyelinase II (nSMNaseII)
enzyme activity that is known to hydrolyze sphingomyelins into pro-apoptotic intracellular molecule ceramide.
Conclusions: The study provides some compelling evidences supporting the anti-metastatic potential of Yukyung
Karne which strongly suggests its possible usage as a promising alternative medicine. Thus, Yukyung Karne may
be used as an anticancer and anti-metastatic agent along with other conventional anticancer therapeutics to
increase their efficacy.
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Background
Ovarian cancer is one of the leading gynecological ma-
lignancies worldwide in which tumor metastasis is asso-
ciated with poor survival of the ovarian cancer patients
[1, 2]. Tumor invasion and metastasis are recognized as
complex and multi-step cellular processes which involve
cell detachment, invasion, migration, intravasation, cir-
culation, implantation, angiogenesis and proliferation
[3]. Degradation of the extracellular matrix (ECM) by
cancer cells through proteases such as matrix metallo-
proteinase’s (MMPs) and serine proteases aids to the
separation of intercellular matrix and promotes tumor
invasion. Incidentally, MMPs such as MMP2 (Gelatinase
A) and MMP9 (Gelatinase B) are secreted by ovarian
cancer cells which in turn correlates with increased occur-
rence of tumor invasion and metastasis. MMPs promote
the epithelial to mesenchymal transition (EMT) by cleav-
ing cell adhesion molecule E-cadherin [4]. Therefore,
interventional strategies against these steps are considered
important to prevent metastasis [5, 6]. Further, loss or
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reduction of trans membrane glycoprotein E-cadherin is
another important manifestation in the EMT program of
tumor cells. It is now well established that loss of E-
cadherin and up-regulation of mesenchymal markers re-
sult in subsequent activation of signal transduction events
such as Wnt/β-catenin pathway that aid to the progres-
sion of metastasis [7]. Not surprisingly, the levels of Wnt
effector β-catenin are tightly regulated in order to control
the expression of its target genes such as c-myc that exerts
a profound effect on cell proliferation, differentiation and
migration [8].
Chemotherapy, surgery and radiotherapy are widely
used in the management of cancer but these are often
associated with adverse effects. To remove these short-
comings in cancer treatment, much attention has shifted
towards the use of complementary and alternative medi-
cines (CAM). Not surprisingly, CAM is now fast emerging
as an effective measure to aid conventional therapies [9].
Natural products have been widely used for centuries and
recent preclinical studies have shown their potential appli-
cations in pharmacology and cancer therapy. Yukyung
Karne has been used for many decades in traditional
Tibetan medicine or Sowa Rigpa for treatment of cancer
[10]. Recently, we have reported the anticancer potential
of Yukyung Karne using ovarian cancer cells in culture
[11]. In the present study, we have investigated the anti-
metastatic properties of Yukyung Karne on ovarian cancer
cells by evaluating its inhibitory effects on cell migration,
cell invasion, EMTand ECM.
Methods
Cell lines and culture conditions
Ovarian cancer cell line SKOV6 was a kind gift of Dr. Anil
Suri (National Institute of Immunology, New Delhi). All
cultures were grown in Dulbecco’s modified Eagle’s
medium containing 10 % heat inactivated fetal bovine
serum, penicillin 100 μg/ml and streptomycin (100 μg/ml).
Cells were incubated at 37 °C in a humidified chamber
under 5 % CO2 atmosphere.
Traditional Tibetan medicine
Yukyung Karne was purchased from the Tibetan Medical
and Astrological Institute, Dharamshala, India. According
to the Tibetan Pharmacopeia [10]. Yukyung Karne is a
mixture of various plant components including: Roots of
Saussurea lappa (C.B. Clarke) (family: Asteraceae), Zingi-
ber officinalis (Roscoe) (family: Zingiberaceae), Aconitum
ferox (Wall.ex Ser) (family:), Corydalis hendersoni (Fedde)
(family: Fumariaceae), and Acorus calamus (L) (family:
Araceae); Fruits of Emblica officinalis (L) (family: Euphorbia-
ceae), Piper longum (L) (family: Piperaceae), and Terminalia
chebula (Rety) (family: Combretaceae); Leaves of Adhatoda
vasica (NEES) (family: Acanthaceae); Seeds of Elletra
cardomomum (L) (family: Zingiberaceae), Coriandrum
sativum (L) (family: Apiaceae), Embelia ribes (Burm, F)
(Family: Myrsinaceae), and Delphinium brunonianum
(Royale) (family: Ranunculaceae); resin of Commiphora
mukul (Hook) (family: Burseraceae); Whole plant of Mecon-
opsis horridula (Hook) (Papaveraceae), and Dracocephyllum
tanguticum (Maxim) (family: Lamiaceae); and Tsothel
(detoxified mercury) as mineral ingredient. All the herbs
were identified by Dr. Tsering Norbu (Menrampa) and the
voucher numbers of plant specimens are available at the
herbarium department of Tibetan Medical and Astrological
Institute for reference.
Sphingomyelinase activity
Neutral sphingomyelinase II (nSMNaseII) enzyme activity
was determined in cell lysate using Amplex Red Sphingo-
myelinase Assay Kit (Molecular probes, Invitrogen) as per
manufacturer’s instructions. The reaction was carried out
for 30 min and fluorescence data was measured in a fluor-
escence microplate reader using excitation at 530 nm and
emission 590 nm. The fluorescence values were normal-
ized with total protein to obtain activity/μg of protein.
Gelatin zymography
Gelatin zymography was performed as described by Al
Dhaheri et al., [12]. Briefly, cells were incubated in serum
free DMEM for 24 h in the presence of Paclitaxel (P),
Yukyung Karne (YK) or P + YK (PY). The conditioned
media was collected and protein was precipitated (1:4) by
acetone. Samples were resuspended in 2x Laemmli buffer
without reducing agent. After boiling, the samples were re-
solved in a 10 % poly acrylamide gel containing 0.1 % gel-
atin. After electrophoresis, gels were washed with 2.5 %
Triton X100 at RT to remove SDS and then incubated
overnight at 37 °C with substrate incubation buffer
(50 mM Tris–HCl pH 7.5, 200 mM NaCl, 10 mM CaCl2).
Bands corresponding to MMP2/9 activity were visualized
by negative staining using Coomassie brilliant blue. Images
were captured using Fluorchem M (Protein Simple, USA).
Crystal violet staining of cells
SKOV6 cells were treated with Yukyung Karne. After
24 h, media was discarded and adhered cells were
washed with 1xPBS and fixed in methanol. Crystal violet
(1 %) solution was added to the cells for 20 min followed
by a wash, and the stained cells were resuspended in
methanol and absorbance was read at 600 nm.
Cell adhesion assay
Cover slips were coated with collagen type I at 37 °C for
1 h. SKOV6 cells were seeded in the presence of Paclitaxel
(P), Yukyung Karne (YK) or P + YK (PY). After16-20 h in-
cubation at 37 °C in a humidified 5 % CO2 incubator,
unadhered cells were gently removed by washing the
coverslips with 1x PBS. Subsequently, the adhered cells
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were fixed in ice cold methanol: acetone (1:1) for
10 min at −20 °C. Cells were stained with Hoechst dye
for 15 min at RT. After rinsing with 1x PBS, images
were captured using confocal microscopy (Nikon A1R).
Adherent cells were counted in five random fields, and
the mean number of cells/field ± SD was calculated.
Colony formation assay
The colony formation assay was performed as described
by Shukla et al., [13]. Briefly, treated cells were incubated
at 37 °C for 14 days and observed regularly for colony
formation and the bright field images were captured with
a Nikon ECLIPSE TE 2000-S inverted microscope and the
number of foci were counted in random fields.
In-vitro invasion assay
The cell migration of SKOV6 cells was studied using
Trans-well plate with 8 μm pore size membrane insert.
Complete medium was added to the membrane and
lower chamber 1 h prior to seeding of cells at 37 °C, 5 %
CO2 humidified incubator. Cells were seeded to the
membrane and treatment was simultaneously given for
4 h. After incubation, inserts were carefully removed
and cells were scraped off using cotton swabs from the
upper surface of the membrane. Cells on lower side of
the membrane were fixed in 10 % methanol followed by
staining with crystal violet (1 %) for 20 min. The mem-
branes were air dried and the number of infiltrated cells
on the lower side of filter was counted by microscopy.
Wound healing assay
Briefly, SKOV6 cells were grown as monolayer at 37 °C,
5 % CO2 in a humidified incubator. A scratch wound
was made using 200 μl yellow pipette across the conflu-
ent monolayer. Cells were cultured with fresh DMEM
supplemented with 10 % fetal bovine serum in the pres-
ence or absence of Yukyung Karne (100 μg) for 24 h.
The extent of wound closure was captured using Nikon
ECLIPSE TE 2000-S inverted microscope.
RNA extraction and quantitative real time PCR (RT-qPCR)
Total RNA was isolated from cells using Trizol reagent
(Invitrogen) as per the manufacturer’s protocol. Reverse
transcriptase-PCR (RT-PCR) was performed with MMuLV
reverse transcriptase (Fermentas) according to the manu-
facturer’s protocol. qRT-PCR was done in an ABI Step
One plus system (Applied Bio system) using specific
primers for N- Vimentin Forward:5’GAGACAGGTGC
AGTCCCTCA, Vimentin Reverse: 5’GAAGGTGACG
AGCCATTTCCT. β Actin served as an internal control.
Western blotting
Cell lysates were prepared in 1x cell lysis buffer (Promega,
USA). Protein concentration was determined by Bradford’s
reagent (Biorad). Equal amounts of protein samples were
resolved in a 10-15 % SDS-PAGE followed by western
blotting (WB). Primary antibodies-E-cadherin, N-cadherin
were procured from Cell Signaling Technology, pFAK
(Tyr397), Caveolin1 (N-20), Integrin5α, Beta catenin (E5),
GSK-3β (H-76) and GAPDH (FL-335) were from Santa
Cruz Biotechnology (USA). The protein bands were
visualized using enhanced chemiluminescence (ECL) from
Santa Cruz Biotechnology (California, USA).
Statistical analysis
Data are expressed as mean ± S.D. Statistical significance
was calculated using Student’s t test. p values of <0.05
were considered significant.
Results
Yukyung Karne elevates the nSMNase II activity
Working on the pharmacological basis of anticancer prop-
erties of Yukyung Karne, we have earlier reported that it is
able to induce cell cycle arrest and apoptosis as well as re-
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Fig. 1 Cell viability and neutral sphingomyelinase II activity in the
presence of Yukyung Karne. a The ovarian cancer SKOV6 cells were
treated in presence of Paclitaxel (Pac, 10 nM), Yukyung Karne (YK, 100 μg)
or PY [Pac (10 nM) + YK (100 μg)] for 24 h and the sphingomyelinase
activity was measured after 30 min. b Cells were treated as above and
the cytotoxic effects were measured by crystal violet staining.. All results
represented here are mean ± S.D. from three independent experiments.
Statistical significance: *, p <0.05; **, p <0.001
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ovarian cancer cell line SKOV6. Since manipulation of
sphingolipid level for ceramide production has been shown
to improve the efficacy of anticancer therapy [14, 15], we
investigated the effect of Yukyung Karne on the activity of
nSMNaseII enzyme in SKOV6 cells. Interestingly, we ob-
served the elevated levels of nSMaseII in SKOV6 cells
treated with YK (100 μg) (p <0.001) confirming its positive
role in ceramide production (Fig. 1a). We also observed
that Yukyung Karne treatment significantly inhibited the
viability of the cells (p <0.001) as evident from the crystal
violet staining of cells (Fig. 1b) further strengthening its
pro-apoptotic property.
Yukyung Karne inhibits collagen -mediated cell adhesion
Since the migratory and metastatic potential of cancer
cells is fore timed by their interaction with endothelial
cells and ECM proteins like collagen [16], we assessed
the effect of Yukyung Karne treatment on cell to matrix
interaction in vitro by collagen binding ability using
ovarian cancer cells. According to our data, a quantum
reduction in adhesion of cancer cells to collagen (84 %)
was observed for Yukyung Karne treated SKOV6 cells
when compared to untreated cells. Interestingly, a sig-
nificant decrease in cell adhesion was also observed for
positive control paclitaxel (p <0.05) and combination of
paclitaxel with YK (p <0.001) suggesting its strong ability
of Yukyung Karne to suppress the adhesion of SKOV6
cells to collagen (Fig. 2a).
Yukyung Karne interferes with the transformation of
SKOV6 cells
Widely accepted hallmarks of cancer include the resistance
of cancer cells to contact inhibition and the enhanced
ability to form independent colonies. We next examined
the inhibitory potential of Yukyung Karne on the colony
forming ability of SKOV6 cells. While the untreated
SKOV6 cells produced 15 ± 3 colonies/field, it was sup-
pressed to 5 ± 1 (p <0.001) on exposure to YK, Pac 7.5 ± 1
(p <0.001) and PY 5.5 ± 1 (p <0.001) (Fig 2b). This result
confirmed the negative effect of Yukyung Karne on the
transformation potential of ovarian cancer cells.
Yukyung Karne inhibits migration and invasion of ovarian
cancer cells
Metastasis of ovarian cancer cells from the primary site to
the neighboring secondary tissues mainly peritoneum and
omentum is the main event in transition of benign to ma-
lignant cancer. To elucidate the role of Yukyung Karne in
inhibiting the migratory potential of SKOV6 cells, we per-
formed trans-well migration and wound healing assays. A
close examination of the invasive potential of Yukyung
Karne using transwell insert (Fig. 3a) revealed a significant
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Fig. 2 Inhibition of cell adhesion to collagen and colony formation in the presence of Yukyung Karne. a SKOV6 cells were grown in presence of
Paclitaxel (Pac, 10 nM), Yukyung Karne (YK, 100 μg) or PY [Pac (10 nM) + YK (100 μg)] and allowed to adhere to collagen-coated (10 μg/ml) cover slips
for 24 h. The adhered cells were quantified using Hoechst dye. b Cells were treated as above and grown in soft agar for 14 days and the number of
colonies was counted. All results represented here are mean ± S.D. from three independent experiments. Statistical significance: *, p <0.05; **, p <0.001
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Fig. 3 (See legend on next page.)
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dependent manner (p <0.001). Further, in wound healing
assay (Fig. 3b), Yukyung Karne severely impaired the
migratory behavior of SKOV6 cells when compared to un-
treated cells by 20 % and 80 % at 6 h and 24 h respectively.
Taken together these results confirm the inhibitory effect
of Yukyung Karne on the migration and invasion potential
of SKOV6 cells.
Yukyung Karne acts as a MMPs inhibitor
Degradation of the ECM by MMPs aids in tumor inva-
sion and thus is a crucial step in the initiation of metas-
tasis [17]. In line with its strong anticancer properties,
we next investigated the inhibitory effect of Yukyung
Karne on both MMP2 and MMP9 activities using gelatin
zymography. As shown in Fig. 4a, there was a marked
inhibition (p <0.05) in the gelatinolytic band correspond-
ing to MMP9 and MMP2 (proenzyme forms) in the con-
ditioned media of the cells treated with Yukyung Karne
when compared to control untreated cells.
Effect of Yukyung Karne on EMT
In order to metastasize, tumor cell undergo an EMT that
is marked by increase in mesenchymal markers such as
vimentin, vitronectin, N-cadherin and decrease in epithelial
markers like E–Cadherin [18]. Since Yukyung Karne
caused down regulation of MMPs, we hypothesized that it
may have a strong bearing on the expression of EMT
markers. Western blot analysis of the Yukyung Karne
treated cells showed low levels of N-cadherin protein
(p <0.05) (Fig. 4b) and a significant inhibition (p <0.01)
in the levels of vimentin mRNA in the Yukyung Karne
treated cells (Fig. 4c). In contrast, as shown in Fig. 4b,
the levels of E-cadherin were found to be significantly
elevated following treatment with PY (p <0.01) and YK
(p <0.01). Thus, the reciprocal expression of epithelial
and mesenchymal markers induced by Yukyung Karne,
suggest its potential as an anti-metastatic agent.
Effect of Yukyung Karne on ECM
To further support the anti-metastatic property of
Yukyung Karne, we also investigated its role in the
modulation of Wnt/β catenin pathway. Binding of Wnt
protein to the receptors triggers activation of β catenin
and its inappropriate activation was often found deregu-
lated in many cancers. Under normal circumstances onco-
protein β-catenin gets phosphorylated by GSK3β and
subsequently ubiquitinylated and targeted for degradation.
Western blot analysis of the Yukyung Karne-treated
SKOV6 cells exhibited a significant reduction in the
Wnt/β catenin effector molecule β-Catenin (p <0.05),
GSK3β (p <0.05), and also its downstream target c-Myc
(p <0.05), (Fig. 5c) [19, 20]. Consistent with a marked
inhibition of ECM components and its cytoskeletal dynam-
ics, the levels of integrin α5 which is crucial for cell to cell
and ECM interaction for adhesion was down-regulated fol-
lowing Yukyung Karne treatment (p <0.001) (Fig. 5c).
To further understand the mechanism of action of
Yukyung Karne, we investigated its effect on the levels of
Caveolin 1, whose down regulation is associated with ac-
tivation of MAP kinase and anchorage independent
growth [21]. Surprisingly, the Yukyung Karne- treated
cells exhibited no appreciable change in the levels of
Caveolin-1 (Fig. 5a, c) while there was a marginal (40 %)
inhibition in the levels of of pFAK which is crucial for
transmitting signals during tumorogenesis (Fig. 5b, c).
Taken together, our present sets of results strongly sug-
gest the inherent potential of Yukyung Karne. Yukyung
Karne exerts an inhibitory effect on the migration of
ovarian cancer cells by regulating the expression of EMT
markers and ECM components.
Discussion
CAMs are fast emerging as an acceptable choice for
treating various chronic diseases including ovarian can-
cer where extensive metastasis to the neighboring organs
like fallopian tubes, uterus, bladder and peritoneal cavity
is a major challenge. In traditional Tibetan medicine,
Yukyung Karne has been used as an effective alternative
treatment for cancer metastasis specifically for ovarian
cancer. Recently, we have shown that Yukyung Karne ex-
hibits several therapeutic effects on ovarian cancer cells
such as induction of growth arrest and apoptosis [11]. In
addition to our earlier observation, we observed a marked
increase in the levels of a critical enzyme nSMNaseII
which is involved in generation of ceramide from sphingo-
myelins in response to apoptotic inducers such as chemo-
therapeutic agents leading to growth inhibition and
apoptosis [14]. Thus, increase in the nSMNaseII activity
appears to be one of the Yukyung Karne’s cytotoxic mech-
anisms. However, the pharmacological basis of its anti-
metastatic property remains elusive. In the present study,
we investigated the anti-metastatic potential of Yukyung
(See figure on previous page.)
Fig. 3 Inhibition of ovarian cancer cell migration and invasion in the presence of Yukyung Karne. a SKOV6 cells were grown in the presence of
Paclitaxel (Pac, 10 nM), or different concentrations of Yukyung Karne (YK 50 μg, 100 μg, 200 μg) or PY [Pac (10 nM) + YK (100 μg)] for 24 h and cell
invasion was determined by using transwell plates. No. of cells infiltrating through 8 μm pore size filter were stained with crystal violet (20 %), air
dried and quantified by microscopy. b SKOV6 cells were grown in the presence of Yukyung Karne (100 μg) and subjected to scratch assay for 6 h
or 24 h. Representative images of 3 independent experiments are shown here. All results are shown as mean ± S.D. from five random fields.
Statistical significance:*, p <0.05, **, p <0.001
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Karne using ovarian cancer cells. Adhesion of cells to
ECM is a crucial event in modulation of cellular processes
including the regulation of anchorage-dependent pro-
cesses. Interestingly, a significant number of cancer cells
failed to adhere to the collagen-coated culture plates in
the presence of Yukyung Karne (Fig. 2). Further, cell mi-
gration is an important mechanism in the metastasis of
high-grade ovarian cancer [22]. We observed a negative
correlation between the number of migratory cells and the
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Fig. 4 Effect of Yukyung Karne on the expression of matrix metalloproteinases, cadherin and vimentin in ovarian cancer cells. a SKOV6 cells were
treated with Paclitaxel (Pac, 10 nM), Yukyung Karne (YK, 100 μg) or PY [Pac (10 nM) + YK (100 μg)] for 24 h and the activity of MMP2 and MMP9
enzymes was assessed by gelatin zymography. SKOV6 cells were treated as in A for 24 h and the cell lysates were either western blotted (WB) for
N- and E-cadherins (b) or quantitated for vimentin mRNA by qRT-PCR (c). The results are represented as mean ± S.D. of three independent experiments.
Statistical significance:*, p <0.05
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of SKOV6 cells were also seen reduced significantly upon
treatment with Yukyung Karne.
Here EMT plays a major role in aiding the tumor cells
to migrate out from the primary site, enter into the cir-
culation and adhere to endothelial cells of target organs.
Cadherin- mediated adhesion plays an important role in
maintaining cell-cell contacts and reducing tumor me-
tastasis [23, 24]. Accordingly, the E-cadherin negative
tumor is a predictor of poor overall survival [25]. In the
present study, we observed a striking correlation in the
E-cadherin level and decrease in mesenchymal markers
such as Vimentin and N-cadherin supporting epithelial
characteristics following treatment with Yukyung Karne
and correlates with decrease in tumorogenicity [26].
Degradation of ECM components is a prerequisite step
for initiation of metastasis [27] and intraperitoneal ovar-
ian cancer metastasis is mediated by adhesion via integ-
rins to peritoneal mesothelial cells. On binding to ECM,
integrin 5α regulates diverse functions in tumor cells in-
cluding migration, invasion, proliferation and survival
through activation of various pathways such as MAPK.
In our study, we observed a significant decrease in integ-
rin 5α expression in the Yukyung Karne treated cells.
Hence, use of known integrin inhibitors could also be a
novel therapeutic strategy to combat cancer. The key
mediator of integrin signal is focal adhesion kinase
(FAK) which functions in cell motility and proliferation
[28, 29]. Increased tumor apoptosis has been reported
earlier following pharmacological inhibition of FAK in a
xenograft cancer model [30]. In the Yukyung Karne-
treated cancer cells, we observed a significant inhibition
in integrin 5α and pFAK gene expression corroborating
the tumor growth inhibitory property of Yukyung Karne
(Fig. 5b, c). E-cadherin is frequently down regulated in
epithelial tumors and a number of studies have shown
that disruption of E-cadherin leads to transcriptional ac-
tivation of oncoprotein ß-catenin [23]. The accumula-
tion of ß-catenin stimulated transcription factors that
enhanced cell proliferation and poor prognosis. Our
study confirmed decreased levels of ß-catenin, pGSK3-ß
and downstream target c-Myc (Fig. 5c) and increased
levels of E-cadherin (Fig. 4b) following Yukyung Karne
treatment.
Besides the well-defined role of major ECM compo-
nents, we also investigated the status of scaffolding pro-
tein Caveolin in this study. Caveolin 1 is ubiquitously
expressed and encodes a major component of membrane
caveolae. It functions as tumor suppressor [31] and con-
tributes to the organization and stability of adherent
junctions through its association with E-cadherin at
junction level. Caveolin 1 is consistently seen lost or
down regulated in malignant ovarian cancers [23]. Inter-
estingly, the level of caveolin1 levels were found up-
regulated in the Yukyung Karne treated SKOV6 cells
suggesting Yukyung Karne as a strong candidate in indu-
cing expression of tumor suppressor caveolin 1 (Fig. 5c).
Consistent with anti-metastatic property of Yukyung
Karne, further our gelatin zymography studies also indi-
cated a marked reduction in the activity of key enzymes
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Fig. 5 Effect of Yukyung Karne on extracellular matrix proteins. SKOV6 cells were cultured on cover slips and treated with Paclitaxel (Pac, 10 nM),
Yukyung Karne (YK, 100 μg) or PY [Pac (10 nM) + YK (100 μg)] for 24 h and processed for immunofluorescence analysis using anti caveolin 1
antibody (a), and with pFAK antibody (b). c Cell extracts were western blotted (WB) to show the levels of β Catenin, pFAK, pGSK3β, c-Myc, Caveolin 1
and Integrin. Actin was used as loading control. Similar results are obtained from three independent experiments
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ECM components during tumor invasion and metastasis
and are abundantly expressed in various malignant can-
cers [32, 33].
Thus, Yukyung Karne seems to exert its anti-metastatic
potential by regulating EMT with increase in E- cadherin
expression and loss of critical intracellular oncoprotein
ß-catenin that has been shown implicated in induction of
EMT in various cancers [7]. However, further in vivo
studies are needed to ascertain its effectiveness in the
treatment of ovarian cancer. Nevertheless, Yukyung Karne
appears to be a good candidate medicine for treating ovar-
ian cancer patients as it exhibits better efficacy than pacli-
taxel. Further, its use in combination therapy along with
conventional chemotherapeutic agent such as paclitaxel
should improve the overall efficacy of treatment.
Conclusions
Our findings provide a multitude of evidences supporting
a strong and potent anti-metastatic property associated
TTM Yukyung Karne. Yukyung Karne effectively counters
a range of anti-metastatic properties of cancer cells in-
cluding adhesion, invasion migration, colony formation,
ECM components, loss of mesenchymal marker and gain
of epithelial marker. Thus, Yukyung Karne appears to be
an ideal CAM that could be used for developing new
therapeutic strategies in the management of ovarian can-
cer metastasis.
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